| Alaska Patients First Llc | |
|
2751 Debarr Rd Ste 310, Anchorage, AK 99508-6804 | |
| (907) 277-9700 | |
| (907) 868-1215 |
| Full Name | Alaska Patients First Llc |
|---|---|
| Type | Facility |
| Speciality | Pain Medicine - Interventional Pain Medicine |
| Location | 2751 Debarr Rd Ste 310, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114566536 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Alaska Patients First Llc 2751 Debarr Rd Ste 310, Anchorage, AK 99508-6804 Ph: (907) 277-9700 | Alaska Patients First Llc 2751 Debarr Rd Ste 310, Anchorage, AK 99508-6804 Ph: (907) 277-9700 |
News Archive
A study from the University of California, Irvine, explains a hitherto unknown mechanism of action for bioactive molecules in commonly used plant-based folk medicines like fennel, camomile and lavender that are used to lower the blood pressure.
Researchers from Johannes Gutenberg University Mainz and the Julius Maximilian University of Würzburg are proposing potential new active substances for treating the dengue virus. Just like Ebola, dengue fever is also caused by a virus for which there is currently no cure and no vaccine and can be fatal.
Viking Systems, a leading worldwide developer, manufacturer and marketer of 2D and 3D visualization solutions for complex minimally invasive surgery, today announced that it has retained Porter, LeVay & Rose, Inc., to advise the Company on its investor relations initiatives.
Following research by Professor Bill Keevil at the University of Southampton showing that copper can significantly reduce the presence of MRSA, the University, in partnership with the Copper Development Association, is hosting a live experiment that will show the effectiveness of antimicrobial copper in preventing MRSA infections.
› Verified 5 days ago